Bristol-Myers Squibb Co (LTS:0R1F)
$ 59.4 -0.61 (-1.02%) Market Cap: 119.70 Bil Enterprise Value: 163.01 Bil PE Ratio: 0 PB Ratio: 6.98 GF Score: 82/100

Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference (Virtual) Transcript

Nov 18, 2020 / 02:15PM GMT
Release Date Price: $64.08 (-0.19%)
Timothy Minton Anderson
Wolfe Research, LLC - MD of Equity Research

Great. Okay. Good morning. I'm Tim Anderson. I'm the large-cap pharma and biotech analyst. And for the -- of Wolfe Research. And for the next 45 minutes, we'll be talking with Bristol-Myers Squibb's Giovanni Caforio. He's the CEO of the company, a role he's been in since 2015. And he's Chairman of the Board since May of 2017. He joined the company in 2000. And prior to becoming CEO, he served as its Chief Operating Officer and Chief Commercial Officer. And prior to joining Bristol, he spent 12 years with Abbott Laboratories in a number of leadership positions.

So we're just going to jump straight into questions, given that we have about 35 minutes. Good morning, Giovanni. Thanks for joining us today.

Giovanni Caforio
Bristol-Myers Squibb Company - Chairman of the Board & CEO

Good morning, Tim. Thank you. Thanks for the opportunity.

Questions & Answers

Timothy Minton Anderson
Wolfe Research, LLC - MD of Equity Research

Let

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot